HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stern, M. E. Articles by Smith, J. A. Search for Related Content PubMed PubMed Citation Articles by Stern, M. E. Articles by Smith, J. A.

Conjunctival T-Cell Subpopulations in Sjögren’s and Non-Sjögren’s Patients with Dry Eye

¹ From Allergan, Inc., Irvine, California; the ³ Clinical Branch and the ² Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; and ⁴ EMMES Corporation, Potomac, Maryland.

PURPOSE. To examine the conjunctiva of patients with Sjögren’s syndrome keratoconjunctivitis sicca (SS-KCS) and non-Sjögren’s keratoconjunctivitis sicca (NS-KCS) for evidence of immune-based inflammation.

METHODS. Conjunctival biopsy specimens were obtained from 15 patients with SS-KCS and 15 with NS-KCS. Immunohistochemistry was performed on frozen sections to characterize and quantify T-cell subtypes (CD3, CD4, and CD8) and markers of immune activation (major histocompatibility complex [MHC] class II: HLA-DR, HLA-DQ) and inflammation (intercellular adhesion molecule [ICAM]-1). The numbers of cells positive for each marker were counted by two masked observers and averaged.

RESULTS. Conjunctival biopsy specimens from patients with SS-KCS or NS-KCS revealed lymphocytic infiltration and increased immunoreactivity for the markers of inflammation and immune activation. The extent of cellular immunoreactivity did not differ significantly between SS-KCS and NS-KCS tissue samples.

CONCLUSIONS. The authors’ findings indicate that patients with SS-KCS or NS-KCS have conjunctival inflammation manifested by inflammatory cell infiltrates and upregulation of expression in markers of immune activation. Clinical symptoms of KCS may be more dependent on T-cell activation and resultant inflammation than previously believed. In addition to tear substitutes, anti-inflammatory therapeutics should be investigated for the treatment of KCS.

This article has been cited by other articles:

				S. Rashid, Y. Jin, T. Ecoiffier, S. Barabino, D. A. Schaumberg, and M. R. Dana Topical Omega-3 and Omega-6 Fatty Acids for Treatment of Dry Eye Arch Ophthalmol, February 1, 2008; 126(2): 219 - 225. [Abstract] [Full Text] [PDF]

				S. Li, K. Nikulina, J. DeVoss, A. J. Wu, E. C. Strauss, M. S. Anderson, and N. A. McNamara Small Proline-Rich Protein 1B (SPRR1B) Is a Biomarker for Squamous Metaplasia in Dry Eye Disease Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 34 - 41. [Abstract] [Full Text] [PDF]

				C. S. De Paiva, A. L. Villarreal, R. M. Corrales, H. T. Rahman, V. Y. Chang, W. J. Farley, M. E. Stern, J. Y. Niederkorn, D.-Q. Li, and S. C. Pflugfelder Dry Eye-Induced Conjunctival Epithelial Squamous Metaplasia Is Modulated by Interferon-{gamma} Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2553 - 2560. [Abstract] [Full Text] [PDF]

				K.-C. Yoon, C. S. De Paiva, H. Qi, Z. Chen, W. J. Farley, D.-Q. Li, and S. C. Pflugfelder Expression of Th-1 Chemokines and Chemokine Receptors on the Ocular Surface of C57BL/6 Mice: Effects of Desiccating Stress Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2561 - 2569. [Abstract] [Full Text] [PDF]

				S. Narayanan, W. L. Miller, and A. M. McDermott Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2445 - 2450. [Abstract] [Full Text] [PDF]

				A. Gulati, M. Sacchetti, S. Bonini, and R. Dana Chemokine Receptor CCR5 Expression in Conjunctival Epithelium of Patients With Dry Eye Syndrome. Arch Ophthalmol, May 1, 2006; 124(5): 710 - 716. [Abstract] [Full Text] [PDF]

				J. Y. Niederkorn, M. E. Stern, S. C. Pflugfelder, C. S. De Paiva, R. M. Corrales, J. Gao, and K. Siemasko Desiccating Stress Induces T Cell-Mediated Sjogren's Syndrome-Like Lacrimal Keratoconjunctivitis J. Immunol., April 1, 2006; 176(7): 3950 - 3957. [Abstract] [Full Text] [PDF]

				P. Aragona, C. Bucolo, R. Spinella, S. Giuffrida, and G. Ferreri Systemic Omega-6 Essential Fatty Acid Treatment and PGE1 Tear Content in Sjogren's Syndrome Patients Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4474 - 4479. [Abstract] [Full Text] [PDF]

				S Tatlipinar and E K Akpek Topical ciclosporin in the treatment of ocular surface disorders Br. J. Ophthalmol., October 1, 2005; 89(10): 1363 - 1367. [Abstract] [Full Text] [PDF]

				A. E. de Salamanca, K. F. Siemasko, Y. Diebold, M. Calonge, J. Gao, M. Juarez-Campo, and M. E. Stern Expression of Muscarinic and Adrenergic Receptors in Normal Human Conjunctival Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 504 - 513. [Abstract] [Full Text] [PDF]

				S. C. Pflugfelder, W. Farley, L. Luo, L. Z. Chen, C. S. de Paiva, L. C. Olmos, D.-Q. Li, and M. E. Fini Matrix Metalloproteinase-9 Knockout Confers Resistance to Corneal Epithelial Barrier Disruption in Experimental Dry Eye Am. J. Pathol., January 1, 2005; 166(1): 61 - 71. [Abstract] [Full Text] [PDF]

				S. Narayanan, W. L. Miller, and A. M. McDermott Expression of Human {beta}-Defensins in Conjunctival Epithelium: Relevance to Dry Eye Disease Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3795 - 3801. [Abstract] [Full Text] [PDF]